Yahoo Web Search

Sign In

Search results

  1. onlinelibrary.wiley.com › doi › full<em>Journal of Veterinary Internal Medicine</em> | ACVIM Journal...

    5 days ago · Background. Benefit of adding a second-line immunosuppressive drug to glucocorticoids for the treatment of non-associative immune-mediated hemolytic anemia (naIMHA) in dogs has not been defined prospectively.

  2. ca.finance.yahoo.com › news › novartis-canada-launches-500-000Novartis Canada launches $500,000 funding initiative to improve...

    9 hours ago · Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities and promoting equitable healthcare for Canadians. In this open call for ideas, Novartis will award $500,000 CAD to non-profit projects focused on improving health equity in three pivotal areas: social/cultural inclusivity of care, health literacy ...

  3. www.frontiersin.org › journals › microbiologyImpact of veterinary pharmaceuticals on environment and their ...

    1 day ago · Human and animal health is put at risk due to horizontal gene transfer (resistance) in the bacterial population (Kivits et al., 2018). The antibiotic resistant genes and antibiotic resistant bacteria reduce the curative ability of antibacterial substances toward human and animal infections.

  4. www.vetclick.com › news › peter-wells-joins-vetsina-animalPeter Wells joins Vetsina Animal Diagnostics as Chairman

    2 days ago · Vetsina Animal Diagnostics has appointed former Global Head of Research and Development with Novartis Animal Health, Dr. Peter Wells as its first Chairman. Dr. Wells has extensive experience in the animal health pharmaceutical industry having held senior positions in major global companies for almost 30 years.

  5. www.novartis.com › careers › career-searchAssociate Director Data Science | Novartis

    22 hours ago · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

  6. www.science.org › doi › 10A molecular glue degrader of the WIZ transcription factor for...

    4 days ago · The most effective oral therapy for SCD is presently hydroxyurea (HU), which confers disease-modifying benefits and improved survival ().The clinical efficacy of HU arises in part from modest reactivation of HbF (median ~15% of total Hb) (4, 5), an indirect consequence of inhibiting ribonucleotide reductase and thus DNA synthesis.

  7. www.theglobeandmail.com › investing › marketsNovartis Canada launches $500,000 funding initiative to improve...

    9 hours ago · Detailed price information for Novartis Ag ADR (NVS-N) from The Globe and Mail including charting and trades.